Lupus Podocytopathy in an Adolescent Nigerian Girl: A Rare Renal Manifestation of SLE
Keywords:
Adolescent, Immunosuppression Lupus podocytopathy, Minimal Change Disease, Nephrotic Syndrome, Nigeria, Systemic Lupus ErythematosusAbstract
Lupus podocytopathy (LP) is a rare renal manifestation of systemic lupus erythematosus (SLE), characterized by nephrotic syndrome and minimal change disease or focal segmental glomerulosclerosis in the absence of immune complex deposition. It is often under- recognized, especially in low-resource settings due to limited access to advanced diagnostic tools. We report the case of a 15-year-old Nigerian female who presented with a 10-month history of recurrent body swelling without other systemic features of SLE. Initial evaluation revealed nephrotic-range proteinuria (6.94 g/24h), hypoalbuminemia (13.1 g/L), positive ANA (1:160), and anti-dsDNA (1:172), with normal renal function. Renal biopsy showed features consistent with minimal change disease and no immune deposits on immunohistochemistry. A diagnosis of lupus podocytopathy was made. She was treated with
high-dose prednisolone and mycophenolate mofetil (MMF), achieving partial remission by 6 months and complete remission by 12 months. Maintenance therapy with azathioprine was commenced thereafter, with sustained remission. In Conclusion, Lupus podocytopathy should be considered in young patients presenting with nephrotic syndrome and positive lupus serologies even in the absence of other systemic manifestations. Early diagnosis and prompt immunosuppressive therapy can result in favourable outcomes. This case underscores theimportance of renal biopsy and serologic testing in evaluating atypical lupus presentations in African clinical settings.
References
1. Parikh SV, Almaani S, Brodsky S, Rovin BH, D'Agati VD, Bomback AS. et al. Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis. 2020;76(2):265–28.
2. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Lupus podocytopathy is a distinct entity. Clin J Am Soc Nephrol. 2005;16(3):1–8.
3. Okafor UH, Uzoh R, Duru I, Odo J. Spectrum of renal disorders in systemic lupus erythematosus patients at a tertiary hospital in Southeast Nigeria. Niger J Clin Pract. 2019;22(3):367–372.
4. Salako BL, Uduagbamen PK, Hamzat MA, Kadiri S, Arogundade FA. Clinical pattern of lupus nephritis among patients in Ibadan, Nigeria. Afr Health Sci. 2018;18(1):47–54.
5. Amoako YA, Ampem‑Amoako Y. Patterns of glomerular disease among SLE patients in Ghana: a histopathologic review. Ghana Med J. 2021;55(4):212–218.
6. Hu WX, Chen YH, Wang SF, Chen H, Liu ZZ, Zeng C. et al. Lupus podocytopathy: A rare form of lupus nephritis. Clin Nephrol. 2014;81(1):30–38.
7. Sinha A. Lupus podocytopathy: an Indian experience. Paediatr Nephrol. 2012;27(5):815–820.
8. Hertig A, Droz D, Lesavre P, Grünfeld JP, Rieu P. Minimal change disease is common in lupus nephritis with nephrotic syndrome. Kidney Int. 2002;61(3):1328–1333.
9. Moroni G, Vercelloni PG, Quaglini S, Gatto M, Gianfreda D, Sacchi L. et al. Long‑term outcome of lupus nephritis with podocytopathy treated with immunosuppressive agents. Clin J Am Soc Nephrol. 2016;11(11):1983–1985.
10. Tanaka R. Lupus podocytopathy: A distinct form of lupus nephritis. Nephrology (Carlton). 2019;24(3):220–227.
11. Dumas G. Isolated nephrotic syndrome in SLE: A French multicentre study of lupus podocytopathy. Nephrol Dial Transplant. 2017;32(8):1325–1332.
12. Chan TM. Lupus nephritis and the podocyte. Clin J Am Soc Nephrol. 2014;9(7):1260–1262.
